Pacira | PCRX - Выручка от реализации

Биржевая цена
23.79
Изменение за день
-0.03 -0.13%
Ежемесячно
4.21%
Ежегодный
-3.14%
Q2 прогноз
22.02




Продажи Изменить Дата
Assertio Holdings USD 29.2M 1.92M 2024-09
Astellas Pharma JPY 571.21B 46.89B 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Ironwood Pharmaceuticals USD 47.71M 74.35M 2025-12
J&J USD 24.6B 610M 2025-12
Ligand Pharmaceuticals USD 59.66M 55.8M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novo Nordisk DKK 79.14B 4.16B 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Xeris Pharmaceuticals USD 85.81M 11.43M 2025-12
Xoma USD 25K 5M 2024-09
Zoetis USD 2.4B 0 2025-12